PFSA — Profusa, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1859807 ·
Last close
$0.35
Market Cap
$210.8K
52W High
$1515.00
52W Low
$0.32
ADV30
2,063,280
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,545,000 | -8,755,000 | 1,042,000 | 719,000 | 28,169,000 |
| Mar 2026 | 0 | — | -4,006,000 | -3,456,000 | 862,000 | 375,000 | 29,060,000 |
| Dec 2025 | 0 | — | -3,570,000 | -8,567,000 | 3,775,000 | 1,778,000 | 30,433,000 |
| Sep 2025 | 0 | — | -21,709,000 | -22,192,000 | 4,250,000 | 3,009,000 | 38,210,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,330,000
Investing CF
$-936,000
Financing CF
$21,946,000
CapEx
$-78,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6143.98
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-172,992,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-42,737,000
Pretax Income TTM
$-42,970,000
Interest Exp TTM
$233,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,706,000 | -35,823,000 | 3,780,000 | 30,433,000 | -26,658,000 | -16,248,000 |
| Dec 2024 | 0 | -4,500,000 | -9,230,000 | 3,073,000 | 122,278,000 | -119,205,000 | -2,066,000 |
| Dec 2023 | 0 | -6,070,000 | -10,281,000 | 1,893,000 | 111,889,000 | -109,996,000 | -4,402,000 |
| Dec 2022 | 0 | -9,443,000 | -20,217,000 | 1,031,000 | 100,802,000 | -99,771,000 | -7,702,000 |
TTM Snapshot
Revenues TTM
$-95,084
NetIncome TTM
$-38,717,214
OpCashFlow TTM
—
Assets (Latest)
$1,042,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FEED | ENvue Medical, Inc. | $235.5K | $0.25 | — |
| GCTK | Glucotrack, Inc. | $149.3K | $0.19 | — |
| SIGY | Sigyn Therapeutics, Inc. | $145.2K | $0.03 | — |
| PREM | Premier Air Charter Holdings Inc. | $393.6K | $0.01 | — |
| ODYY | Odyssey Health, Inc. | $771.5K | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
2026-11-12 12:30 · Yahoo
Profusa Receives ISO 13485:2016 Certificate from GMED
2026-10-15 10:30 · Yahoo
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
2026-09-24 15:01 · Yahoo
Profusa, Inc. Receives Nasdaq Compliance Determination
2026-09-15 10:00 · Yahoo
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
2026-08-31 12:50 · Yahoo
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
2026-08-20 14:49 · Yahoo
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
2026-08-20 12:30 · Yahoo
Profusa vies for potential G3 Vision Labs acquisition
2026-08-03 11:17 · Yahoo
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
2026-07-27 14:38 · Yahoo
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
2026-07-27 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.